https://www.healthwiretaiwan.com/article/835539648-codexis-to-report-second-quarter-2025-financial-results-on-august-13
Codexis to Report Second Quarter 2025 Financial Results on August 13 | Health Wire Taiwan
https://www.selectscience.net/article/codexis-and-molecular-assemblies-partner-to-transform-the-field-of-dna-synthesis
Codexis and Molecular Assemblies partner to transform the field of DNA synthesis
The partnership aims to accelerate the commercialization of enzymatic DNA synthesis
https://marketchameleon.com/Overview/CDXS/ATMStraddleHistory/
CDXS At-the-Money Straddle Performance Codexis
View historical at-the-money option straddle performance for Codexis (CDXS), including different delta-neutral hedging techniques and week-by-week straddle...
at thestraddle performancecdxsmoneycodexis
https://www.biopharmaboardroom.com/news/13/4226/codexis-and-axolabs-partner-to-evaluate-enzymatic-rna-manufacturing-platform.html
Codexis and Axolabs Partner to Evaluate Enzymatic RNA Manufacturing Platform
Codexis and Axolabs Partner to Evaluate Enzymatic RNA Manufacturing Platform
codexispartnerevaluateenzymaticrna
https://www.biospace.com/press-releases/codexis-to-participate-in-td-cowen-45th-annual-health-care-conference
Codexis to Participate in TD Cowen 45th Annual Health Care Conference - BioSpace
annual health care conferenceto participatetd cowen
https://www.dcatvci.org/top-industry-news/codexis-files-lawsuit-against-enzymeworks-in-biocatalysts-dispute/
Codexis Files Lawsuit Against EnzymeWorks in Biocatalysts Dispute - DCAT Value Chain Insights
Sep 8, 2021 - Codexis, Inc., a developer of biocatalysts for the pharmaceutical and fine chemical industries, has filed a lawsuit against EnzymeWorks and its founder, Junhua...
https://www.biospace.com/codexis-to-report-second-quarter-2024-financial-results-on-august-8
Codexis to Report Second Quarter 2024 Financial Results on August 8 - BioSpace
second quarter
https://roboforex.com/beginners/info/charts/stock_rst/cdxs/
NASDAQ:CDXS stock price chart - Codexis Inc. - RoboForex
Live CDXS chart and quotes. Codexis Inc. is traded on NASDAQ. Bid 12.7 USD, ask 12.85 USD. Explore USA stocks and CFDs in 2026.
stock price chartnasdaqcdxscodexisinc
https://www.codexis.com/
Codexis | RNA Manufacturer | Enzyme Biocatalysis Solutions
Mar 4, 2026 - Codexis: RNA manufacturing and custom enzyme engineering for pharmaceuticals and siRNA therapeutics.
codexisrnamanufacturerenzymebiocatalysis
https://ir.codexis.com/sec-filings/all-sec-filings/content/0001193125-12-347356/d351774dex104.htm
August 9, 2012 - EX-10.4 - 10-Q: Quarterly report pursuant to Section 13 or 15(d) | Codexis, Inc....